H1B Salary Data

Home › Employers › Pacific Life Lines, Inc.

Pacific Life Lines, Inc.: H-1B salaries and sponsorship

Pacific Life Lines, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $104,062.

Applications (LCAs)3
Certified3
Employer addressSan Francisco, CA
H-1B dependent employerNo
Median offered salary$104,062
Middle half of salaries$104,062–$133,411
10th–90th percentile$104,062–$151,020

Does Pacific Life Lines, Inc. sponsor H-1B visas?

Pacific Life Lines, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 1, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Clinical Staff Perfusionist2$104,062
Perfusionist1$162,760

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$104,062
FY20241$104,062
FY20251$162,760

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Perfusionist$162,760–$273,832
Level IV
Redwood City, CAApr 1, 2025Sep 27, 2025Certified
Clinical Staff Perfusionist$104,062–$217,900
Level IV
Redwood City, CAMay 31, 2023Oct 1, 2023Certified, then withdrawn
Clinical Staff Perfusionist$104,062–$217,900
Level IV
Redwood City, CAMay 31, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).